Detection of some antioxidant markers in saliva of patients with beta thalassemia major
DOI:
https://doi.org/10.36320/ajb/v11.i1.8035Keywords:
beta-thalassemia major, secretory status, ferritin, AntioxidantsAbstract
Background : Although evaluation and maintenance of antioxidant defence can be useful in protecting β-thalassemia patients from more serious complications of the disease, there are limited studies about assessment of antioxidant capacity in beta-thalassemic patients particularly in saliva.
Methodology:Thirty patients with β thalassemia major were involved in this study in thalassemia center / Ebn- Albalady hospital in Baghdad, and fifteen normal subjects with matched age and sex were also involved and considered as control group. Age, gender, blood groups, BMI, secretory status, and antioxidant markers were determined in the saliva of normal and diseased subjects, however the status of HCV infection, liver and spleen are evaluated in beta-thalassemic patients.
Downloads
References
Thein SL. Genetic modifiers of beta-thalassemia. Haematologica.2005; 90(5): 649-60.
Vichinsky EP . Changing patterns of thalassemia worldwide. Ann N Y AcadSci, 2005;1054:18-24.
Al-Allawi NA, Jubrael JM, and Hughson M (2006): Molecular characterization of beta-thalassemia in the Dohuk region of Iraq. Hemoglobin, 30(4): 479-86.
RasheedNE, and Ahmed SA. Effect of ß-Thalassemia on some Biochemical Parameters.2009;MEJFM, 7(2): 1-6.
Olivieri N .The β -thalassemias. N Engl J Med.1999; 341(2):99-109.
Clarke G M and Higgins T N .Laboratory investigation of hemoglobinopathies and thalassemias: Review and Update. Clin Chem.2000; 46 (8B): 1284-1290.
Wonke B .Clinical management of beta-thalassemia major.2001;SeminHematol, 38(4): 350-9.
Rund D, and Rachmilewitz E .Beta-thalassemia. New Eng J Med.2005; 353(11): 1135-46.
Galanello R and Origa R .Beta-thalassemia. Orphanet Journal of Rare Diseases.2010; 5:11.
Cappellini MD, Cohen A, Eleftheriou A, Piga A, Porter J and Taher Ali .Guidelines for the Clinical Management of Thalassaemia, 2nd revised edition. Cyprus: Thalassaemia International Federation.2008;ISBN-13.
Yardumian A, Telfer P and Darbyshire P .Standards for the clinical care of children and adults with thalassaemia in the UK.2008 ; 2nd edition. Thalassaemia Society, London, UK.
Prati D . Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major. 2000;VoxSanguinis, 79(3):129–37.
Ghone RA, Kumbar KM, Suryakar AN, Katkam RV and Joshi NG . Oxidative stress and disturbance in antioxidant balance in beta thalassemia major. Indian J Clin Biochem.2008;23(4):337-40.
Saad GS, Musallam KM and TaherAT. The surgeon and the patient with β-thalassaemia intermedia. Brit J Surg. 2011; 98(6):751–60.
erdoukas V, Farmaki K, Carson S, Wood J and Coates T. Treating thalassemia major-related iron overload: the role of deferiprone. J Blood Medicine. 2012; 3:119-129.
Modell B, Khan M, Darlison M, Westwood M A, Ingram D and Pennell D J . Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance.2008;10 (1): 42.
Telfer PT, Warburton F, Christou S, Hadjigavriel M, Sitarou M, and Kolnagou A . Improved survival in thalassemia major patients on switching from deferoxamine to combined chelation therapy with desferrioxamine and deferiprone. Haematologica.2009;94 (12):1777-8.
Ferro E, Visalli G, Civa R, La Rosa MA, Randazzo Papa G, Baluce B, D'Ascola DG, Piraino B, Salpietro C and Di Pietro A.Oxidative damage and genotoxicity biomarkers in transfused and un- transfused thalassemic subjects. Free RadicBiol Med.2012;53(10):1829-1837.
Zarina AL, Norazlin KN, Hamidah A, Aziz DA, Zulkifli SZ and Jamal R . Spectrum of infections in splenectomized thalassaemia patients. Med J Malaysia.2010; 65 (4):283–5.
Piga A, Serra M, Longo F, Forni G, Quarta G, Cappellini MD, and Galanello R . Changing patterns of splenectomy in transfusion-dependent thalassemia patients. Am J Hematol.2011; 86(9):808-10.
Belhoul KM, Bakir ML, Saned MS, Kadhim AM, Musallam KM and Taher AT . Serum ferritin levels and endocrinopathy in medically treated patients with β-thalassemia major. Annals Hematology2012; 91(7): 1107-14.
Cighetti G, Duca L, Bortone L, Sala S, Nava I, Fiorelli G and Cappellini MD .Oxidative status and malondialdehyde in beta-thalassaemia patients. Eur J Clin Invest.2002;32(1):55–60.
Dhawan V, Kumar KR, Marwaha RK, Naravan S, and Kamgar M . Antioxidant Status in Children with Homozygous β-Thalassemia. Ind Pedi.2005;42(11):1141-1145.
Hamed EA and ElMelegy NT . Renal functions in pediatric patients with beta-thalassemia major: relation to chelation therapy: original prospective study. Italian J Pediatr.2010;36:39-
Cakmak A, Soker M, Koc A and Aksoy N . Prolidase activity and oxidative status in patients with thalassemia major. J Clin Lab Analysis2010;24:6-11.
Luglie PF, Campus G, Deiola C, Mela MG and Gallisai D . Oral condition, chemistry of saliva and salivary levels of streptococcus mutants in thalassemic patients. Clin Oral Investig.2002; 6 (4): 223-6.
Sculley DV and Langley-Evans SC. Salivary antioxidants and periodontal disease status. ProcNutr Soc.2002; 61: 137-43.
Norri M I M . Orofacial, salivary and radiographic changes in major Thalassemic patients in Mosul. A Master thesis, oral medicine, Baghdad university.2004; p: 13.
Rai B, Kharb S, Jain R and Anand SC . Salivary lipid peroxidation product malondialdehyde in various dental diseases. World J Med Sci.2006; 1(2):100-101.
Khalili J, and Biloklytska HF . Salivary malondialdehyde levels in clinically healthy and periodontal disease individuals.2008;Oral Dis, 14 (8): 754-60.
Ahmed S K . Biochemical and immunological analysis of saliva and serum with evaluation of the oral health status in thalassemia major patients in Mosul. A master thesis, oral medicine, Baghdad University.2008;pp: 29-37.
Malath N, Ja’afar BDS, Fawaz D and Al-Aswad . Oro-facial manifestations, microbial study and salivary enzyme analysis in patients with β-Thalassemia Major. J BaghColl Dentistry.2012; 24(1):52-56.
Muaid S A S and Zaidan T F . Oro-facial manifestations, oxidative stress marker and antioxidant in serum and saliva of patients with Beta thalassemia major. J BaghColl Dentistry.2015; 27(2):93-97.
Barreira TV, Harrington DM, Staiano A E, and Heymsfield SB . Body adiposity index, body mass index, and body fat in white and black adults. J Am Med Associ.2011;306(8): 828- 830.
WHO expert consultation .Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet.2004; 157-163.
Levine PH . Blood group antigens and antibodies as applied to the ABO and Rh systems. Ortho Diagnostic System Inc. New Jersey.1969; P: 69-70.
WeatherburnMW . Phenol-hypochlorite reaction for determination of ammonia. Anal Chem.1967;39:971-974.
Fossati P, Prencipe L, and Berti G . Use of 3, 5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem.1980; 26(2):227-31.
Doumasa BT, Watson WA, and Biggs HG . Albumin standards and measurement of serum albumin with bromocresol green. ClinChim Acta.1971; 31: 87-96.
Asadi-Pooya AA, and Karamifar H . Body mass index in children with beta-thalassemia major. Turk J Haematol.2004; 21(4): 177-180.
Gomber S, and Dewan P . Physical growth patterns and dental caries in thalassemia. Ind. Pediatr.2006; 43:1064-1069.
Saleem L, and Al-Ani MH . Impaired glucose tolerance test among B thalassemia patients in Hawler province, Iraq. Mid-East J Internal Med.2013; 6(3): 14-20.
Salih K M, and Al-Mosawy W F . Evaluation some consequences of thalassemia major in splenectomized and non-splenectomized Iraqi patients. Int J Pharm Pharmceut Sci.2013; 5 (4): 385-388
Kattamis C, Liakopoulou T, and Kattamis A . Growth and development in children with thalassemia major. Act Pediatr Scand.1990; 1:111-7.
Spiliotis BE .β-Thalassemia and normal growth: are they compatible? Eur J Endocrinol.1998;139:143-4.
Filosa A, Di-Maios, Esposito G, De-Martinis F, De-Terlizzi F. Persistence of delayed adrenarche in boys with thalassaemia. J PedEndocrinol Metabol.2001; 14:407-14.
Abdulzahra MS, Al-Hakeim HK, and Ridha MM (2011): Study of the effect of iron overload on the function of endocrine glands in male thalassemia patients. Asian J Transfus Sci, 5: 127–131.
Wazirzai AH, Ashfaque A, and Herzig JW . Association of blood group A with increased risk of coronary heart disease in the Pakistani population. Pak J Physiol.2005; 1(1): 1-3.
Sherwani SK, Ahmad H, Ahmad T, Hussain T, Akbar S, Zaidi SA and Kazmi SU . Status of Secretor and Non–Secretor with Respect to ABO Blood Group System in Young Population in Karachi-Pakistan. World J Med Sci.2014; 10 (1): 22-25.
Adaay M H, Al-Anzy M M, Al-Samarrai A-M H, Al-TikritiK A, and Al-SamarraiF A . Some Observations on the Occurrence of β-Thalassemia in Mosul. Iraqi J Med Sci.2011; 9 (3):270-274.
. Kadim MH . A statistical analysis of blood types and their relation some disease in Iraq. MSc thesis, Baghdad Univ, Iraq.1983.
Jaff MS, Bilbas FAH . Frequency of the ABH blood group antigen secretors among kurds. Zanco J Med Sci.2007;11(2):15-19.
D’Adamo PJ, and Kelly GS . Metabolic and immunologic consequences of ABH secretor and Lewis subtype status. Altern Med Rev.2001;6(4): 390–405.
JaffMS .Higher frequency of secretor phenotype in O blood group – its benefits in prevention and/or treatment of some diseases. Int J Nanomedicine.2010; 5:901–905.
Akhter S, Kibria GM, Akhter NR, Habibullah MM, Islam SMK, and Zakariah M . ABO and Lewis blood grouping with ABH secretor and non-secretor status: A cross sectional study in Dhaka. Faridpur Med Coll J.2011; 6(1):38-40.
Suvarna J, Ingle H, and Deshmukh CT . Insulin resistance and beta cell function in chronically transfused patients of thalassemia major. Ind j Pediatr.2006; 43:393-400.
Jaruratanasirikul S, Chareonmuang R, Wongcharnchailert M, Laosombat V, Sangsupavanich P, and Leetanaporn K . Prevalence of impaired glucose metabolism in β-thalassemic children receiving hyper transfusions with a suboptimal dosage of iron-chelating therapy. Eur J Pediatr.2008; 167:873-876.
Sultana N, Sadiya S, and Rahman MH . Correlation between serum bilirubin and serum ferritin level in thalassaemia patients. Bangladesh J Med Biochem.2011; 4(2): 6-12.
Mansi K M, and Aburjai T A . Lipid profile in Jordanian children with β-thalassemia major. InternatJHematolOncol.2008; 18(2): 93-98.
Amile M, Besharati S, Nemati K, and Zamani F . Relationship between elevated liver enzyme with iron overload and viral hepatitis in thalassemia major patients in Northern Iran. Saudi Med J.2008; 29(11):1611-1615.
Khan DA, Asma N, Anwar M and Farooq A .Deferiprone challenge test for monitoring iron overload in hepatitis positive thalassemic major patients. Internat J ClinExperim Med.2010; 3: 122-128.
Jaidef S, Meena V, and Sangeeta P . Study of serum ferritin level, sGOT, sGPT, and Hepatitis B status in multitransfused thalassemia patients. J Advan Res Biol Sci.2011; 3(2):63-65.
Munir B, Iqbal T, Jamil A, and MuhammadF .Effect of β-Thalassemia on Hematological and Biochemical Profiles ofFemale Patients. Pak J life Soc Sci.2013; 11(1): 25-28.
Albahadle A-K J, Abdul-Abass A, and Ali HA . Prevalence of hepatitis C infection among multitransfused thalassemia major patients in Ibn-Albalady Center of thalassemia. Q M J.2013; 9 (15):73-84.
Saeed U, Waheed Y, Ashraf M, Waheed U, Anjum S, and Afzal MS . Estimation of hepatitis B virus, hepatitis C virus, and different Clinical parameters in the thalassemic population of Capital Twin cities of Pakistan. Virol Res Treat.2015; (6):11–16.
Morsy M-M F, Alnajjar A A, Almuzainy IS, Alhawsawi ZM, Alserafi MH, and Ahmed AA . Splenectomized versus non-splenectomized patients with thalassemia major. Saudi Med J.2008; 29(9): 1310-1314.
Streckfus CF and Bigler LR (2002): Saliva as a diagnostic fluid. Oral Diseases, 8:69-76.
Ahmadi MF, Davoodi P, Dalband M, and Hendi SS . Saliva as a Mirror of the Body Health. DJH.2010; 1 (2):1-15.
Tolba MR, Soliman NAA, El- Kamah GY, and EL-Shehaby AI . Oxidative Stress Parameters in Beta-Thalassemia. Intern J Life Sci Res.2015; 3(4):1-7.
Zucker SD, Horn PS and Sherman KE . Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology.2004; 40:827-35.
Bazvand F, Shams S, Esfahani M B, Koochakzadeh L, Monajemzadeh M, Haghi Ashtiani M-T and Rezaei N . Total Antioxidant Status in Patients with Major β-Thalassemia. Iran J Pediatr.2011; 21(2): 159-165.
Şimşek F, Öztürk G, Kemahli S, Deniz E, and Alev H . Oxidant and antioxidant status in beta thalassemia major patients. Ankara Univ Tip Fak Mec.2005; 58:34-8.
Martínez-Romero R, Martínez-Lara E, Aguilar-Quesada R, Peralta A, Oliver FJ, and Siles E . PARP-1 modulates deferoxamine-induced HIF-1alpha accumulation through the regulation of nitric oxide and oxidative stress. J Cell Biochem.2008104:2248–2260.
Awadallah SM, Atoum MF, Nimer NA, and Saleh SA .Ischemia modified albumin: An oxidative stress marker in β-thalassemia major. ClinicaChimica Acta.2012; 413: 907–910.
Hosen B, Karmokar NC, Karim F, Al Mahmud R, and Uddin M . Association of AST, ALT, ALB and Total Protein with Beta-thalassemia in Bangladeshi Population. Internation J Adva Res.2015; 3(1): 991-995.
Chawla R,Goyal N,Calton R,and Goyal S . Ischemia modified albumin: A novel marker for acute coronary syndrome. Indian J Clin Biochem.2006; 21(1): 77–82.
Sbarouni E, Georgiadou P, and Voudris V . Ischemia modified albumin changes-review and clinical implications. ClinChem Lab Med.2011; 49:177–84.
Tektook , N.K.(2005).Bacteriological and Serological study in Diabetic patients with urinary tract infections and diabetic retinopathy.M.Sc. thesis. College of Science. Al-Mustansiriyah University, Iraq.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Iyden Kamil Mohammed
This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.
